Free Trial

Cytosorbents (CTSO) SEC Filings & 10K Form

Cytosorbents logo
$1.01 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.00 -0.01 (-0.50%)
As of 04:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cytosorbents SEC Filings

DateFilerForm TypeView
04/23/2025
3:28 PM
Cytosorbents (Filer)
Form DEFA14A
04/23/2025
3:31 PM
Cytosorbents (Filer)
Form ARS
04/17/2025
3:05 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2025
1:22 PM
Cytosorbents (Subject)
Skylands Capital, LLC (Filed by)
Form SCHEDULE 13G
04/04/2025
6:05 AM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
4:10 PM
Cytosorbents (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/31/2025
4:12 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
6:00 AM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2025
8:00 PM
BATOR MICHAEL G. (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
6:26 PM
Cytosorbents (Issuer)
Sobel Alan D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
6:27 PM
Chan Phillip P. (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
6:28 PM
Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
6:29 PM
Capponi Vincent (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
6:07 AM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
9:22 AM
AVENIR CORP (Filed by)
Cytosorbents (Subject)
Form SCHEDULE 13G/A
01/31/2025
5:49 PM
Cytosorbents (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G
01/22/2025
7:29 PM
Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
7:31 PM
Chan Phillip P. (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
7:32 PM
Cytosorbents (Issuer)
Sobel Alan D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
7:33 PM
Cytosorbents (Issuer)
Deliargyris Efthymios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
7:34 PM
Capponi Vincent (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
7:35 PM
BATOR MICHAEL G. (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
8:05 AM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
12:26 PM
Cytosorbents (Subject)
Skylands Capital, LLC (Filed by)
Form SCHEDULE 13G
12/23/2024
3:05 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
6:00 AM
Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
7:00 AM
Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
6:17 AM
Cytosorbents (Filer)
Form 424B5
12/09/2024
6:18 AM
Cytosorbents (Subject)
Form FWP
12/09/2024
6:08 AM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2024
8:00 PM
Capponi Vincent (Reporting)
Cytosorbents (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
8:00 PM
Cytosorbents (Issuer)
Deliargyris Efthymios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:25 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
4:22 PM
Cytosorbents (Filer)
Form 424B5
10/01/2024
7:06 AM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
11:15 PM
Cytosorbents (Filer)
Form EFFECT
09/26/2024
4:05 PM
Cytosorbents (Filer)
Form S-3/A
08/20/2024
3:51 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
5:57 PM
Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/16/2024
5:58 PM
Cytosorbents (Issuer)
MARIANI PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:28 PM
Cytosorbents (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
Virtually Limitless Energy? (Ad)

A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts. This obscure company could be at the center of the next trillion-dollar energy revolution.

One company’s discovery could change power forever
08/16/2024
4:12 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2024
4:11 PM
Cytosorbents (Filer)
Form 424B5
07/26/2024
4:14 PM
Cytosorbents (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/03/2024
7:01 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
3:31 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
3:35 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
4:23 PM
Cytosorbents (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CTSO) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners